Under constraction
Showing posts with label AboutUs. Show all posts
Showing posts with label AboutUs. Show all posts
Monday, July 18, 2016
-
FDA Warning Letters go to Manufacturers in China, Ireland, Australia and India In the Month of May-2018 The US FDA has i... -
The U.S. Food and Drug Administration (FDA) inspected Chinese firm M/s Baoying County Fukang Medical Appliance Co. revealed se... -
The U.S. Food and Drug Administration (FDA) inspected Rome drug manufacturing facility, Tubilux Pharma S.p.A. at... -
The petition states the approval of Cadila’s drug as a biosimilar has caused Roche “irreparable damage” in violation of applicable law for ...
-
The U.S. Food and Drug Administration (FDA) inspected a major drug manufacturing facility, Hospira Inc., a Pfizer... -
GMP Violations like to highlighted few key Violations with respective to cGMP for ease of understanding. The Mot... -
FDA Guide to Equipment design, size, and location 211.63 Subpart D--Equipment Sec. 211.63 Equipment design, size, and location ... -
ICH Q11: Draft Q&A Document Reaches Step 2b The ICH Q11 Questions and Answers (Q&As) on the Development and Manufacture of...
-
By the PDA Post Approval Change: Innovation for Availability of Medicines (PAC iAM SM ) Task Force* The seamless delivery of hi... -
The agency met with the representatives of the East African Community to discuss the creation of a networking agency. Th...
-
Featured Post
FDA Guideline to 21 CFR PART 211 SUB PART-D EQUIPMENT #21CFR #PART211 #EQUIPMENT #PBS #PBSINDIA
FDA Guideline to 21 CFR PART 211 SUB PART-D EQUIPMENT #21CFR #PART211 #EQUIPMENT #PBS #PBSINDIA GMP News, GMP guidelines,...
-
FREE GMP NEWS
Subscribe To
Posts
All Comments
